Track topics on Twitter Track topics that are important to you
NIATx With Product Training Line Support Substance Disorders PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest NIATx With Product Training Line Support Substance Disorders articles that have been published worldwide.
We have published hundreds of NIATx With Product Training Line Support Substance Disorders news stories on BioPortfolio along with dozens of NIATx With Product Training Line Support Substance Disorders Clinical Trials and PubMed Articles about NIATx With Product Training Line Support Substance Disorders for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NIATx With Product Training Line Support Substance Disorders Companies in our database. You can also find out about relevant NIATx With Product Training Line Support Substance Disorders Drugs and Medications on this site too.
Substance use disorders (SUD) frequently co-occur with posttraumatic stress disorder (PTSD). Little is known, however, about how individuals with a single SUD diagnosis (relating to only one substance) compare to individuals with poly-SUD diagnoses (relating to more than one substance) on substance use and PTSD treatment outcomes. To address this gap in the literature, we utilized data from a larger study investigating a 12-week integrated, exposure-based treatment (i.e., Concurrent Treatment of PTSD and Su...
Substances of abuse are characterized by their rewarding effects and engagement of reward pathways in the brain. However, these substances also provide rapid relief of negative affect, and thus are highly negatively reinforcing. Accordingly, negative affectivity and other affective vulnerabilities (factors related to the experience of affect) are strongly linked to problematic substance use and substance use disorders. In this review, we provide a critical overview of the literature on affective vulnerabili...
Pathological substance use disorders represent a major public health crisis with limited effective treatment options. While much work has been done to understand the neuronal signaling networks and intracellular signaling cascades associated with prolonged drug use, these studies have yielded few successful treatment options for substance use disorders. In recent years, there has been a growing interest to explore interactions between the peripheral immune system, the gut microbiome, and the CNS. In this re...
The HospitalitY (HY) intervention is a novel recovery oriented intervention for people with psychotic disorders in which peer support and home-based skill training are combined in an eating club. A feasibility study was conducted to inform a subsequent randomised trial.
Gambling and money games disorder. Pathological gambling was recently re-categorized, in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), into the group of substance-related and addictive disorders and renamed « gambling disorder ». This change confirms the conceptualization of gambling disorder as an addiction. The prevalence of this trouble has been shown to be 1.2-7.1% in the general population. The gambling disorder presents many psychiatric comorbidities and sub...
People living with HIV often experience mental health disorders and engage in substance use. Evidence, however, is limited about the influence of mental health disorders and substance use on non-adherence to ART. We conducted a cross-sectional study among 682 HIV-positive people on ART in Nepal. We measured their depressive symptoms, anxiety, stress levels, substance use, and non-adherence to ART. We developed logistic regression models to examine the association of mental health disorders and substance use...
Researchers offer Through the Diamond Threshold, a culturally relevant, community-based training program to increase awareness and promote healing related to substance use disorders (SUD) among American Indians (AIs). For providers, this program seeks to promote greater cultural responsiveness, empathy, cultural humility, and effectiveness in SUD treatment provision. Largely interactive in nature, the activities offer an opportunity for participants to immerse themselves in an AI experience through the use ...
Major depressive disorder (MDD) is the most prevalent comorbid mental disorder among people with substance use disorders. The MDD can be both primary and substance-induced and its accurate diagnosis represents a challenge for clinical practice and treatment response. Recent studies reported alterations in the circulating expression of inflammatory mediators in patients with psychiatric disorders, including those related to substance use. The aim of the study was to explore TNF-α, IL-1β, CXCL12, CCL2, CCL1...
The specialized literature provides solid evidence that substance use disorders (SUD) and personality disorders (PD) are interrelated. Given the relative novelty of the Alternative Model for PD, there are still few studies that have analyzed the relationship between the different facets, substance use disorder, and the various consumption profiles.
Self-stigma is a result of internalizing negative stereotypes by the affected person. Research on self-stigma in substance use disorders (SUD) is still scarce, especially regarding the role of childhood trauma and subsequent posttraumatic disorders.
Hearing loss is common and associated with poorer health and impeded communication. Little is known about the association between hearing loss and substance use disorders in the general population. The objective of this study was to assess substance use disorder prevalence among individuals with hearing loss, versus those without hearing loss, in a nationally representative sample of adults.
Serotonergic function is known to fluctuate in association with light and temperature. Serotonin-related behaviors and disorders similarly vary with climatic exposure, but the associations are complex. This complexity may reflect the importance of dose and timing of exposure, as well as acclimation. This cross-sectional study tests how average climate exposures (ambient temperature and solar insolation) vary with the prevalence of a group of SSRI-treated disorders. For comparison, we similarly studied a gro...
Several cardiotoxic substances impact heart failure incidence. The burden of comorbid tobacco or substance use disorders among heart failure patients is under-characterized. We describe the burden of tobacco and substance use disorders among hospitalized heart failure patients in the U.S.
Public Safety Personnel (PSP; e.g. correctional workers, dispatchers, firefighters, paramedics, police) are frequently exposed to potentially traumatic events (PTEs). Several mental health training program categories (e.g. critical incident stress management (CISM), debriefing, peer support, psychoeducation, mental health first aid, Road to Mental Readiness [R2MR]) exist as efforts to minimize the impact of exposures, often using cognitive behavioral therapy model content, but with limited effectiveness res...
Compared with other psychiatric disorders of similar heritabilities, the progress of substance use disorders (SUD) genetics has been slow. With the growing availability of large-scale biobanks with extensive phenotypes from electronic health records (EHR) and genotypes across millions of individuals, this platform is the next tool to accelerate SUD genetics research.
Although victimization is a known contributor to the development of substance use disorders, no research has simultaneously examined how characteristics of victimization experienced over time, such as the type of abuse, the presence of poly-victimization, closeness to perpetrator(s), life threat or fear, and negative social reactions to disclosing victimization, cluster into profiles that predict substance use disorders.
To examine the age-specific risk of past-year substance use disorders (SUDs) associated with use and misuse of prescription opioids, stimulants, sedatives and tranquilizers.
Research on women with substance use disorders has expanded, yet knowledge and implementation gaps remain.
Substance abuse among adolescents and young adults is common. For 5 to 7 % of young people, substance use become problematic, take a function in the psychic equilibrium of the subject and will stop the adolescent process. For some, continuing substances use will be associated with the development of a primary or secondary psychiatric disorder. People with a first psychotic episode (FEP) with cannabis use will stop their use for 50 % of them, with early management of the disorder, without targeted addict...
Substance use disorders (SUDs), including those for alcohol, stimulants, tobacco, opioids and cannabis, in patients with bipolar disorder are a major clinical and public health problem, and are present in the majority of these patients. Nonetheless, the development of effective pharmacological treatments for co-occurring SUDs in bipolar illness have not been well-developed and may be an important practical reason for the reduced effectiveness of these medications in community practice.
Gabapentin (GBP) is an anticonvulsant medication that is also used to treat restless legs syndrome (RLS) and posttherapeutic neuralgia. GBP is commonly prescribed off-label for psychiatric disorders despite the lack of strong evidence. However, there is growing evidence that GBP may be effective and clinically beneficial in both psychiatric disorders and substance use disorders. This review aimed to perform a systematic analysis of peer-reviewed published literature on the efficacy of GBP in the treatment o...
It is indicated that Oman is witnessing an increase in issues pertinent to alcohol and psychoactive substance use.
High rates of mental disorders have been reported for prison populations. Understanding patterns of comorbidity may be essential for the development of adequate treatment interventions. The present study aimed to assess the underlying structure of comorbidity between mental health and substance use disorders in prison populations.
Shame has been hypothesized to both contribute to and protect against problematic substance use, yet no systematic reviews of these relationships exist. We identified 42 studies of the empirical associations between shame and substance use or substance use-related problems in order to elucidate this relationship. A meta-analysis of 14 samples found no significant association between shame and substance use (r = 0.00). A meta-analysis of 18 samples found a significant association between shame and substa...